Verification of the Correct Insertion of a Central Venous Catheter

NCT ID: NCT06109584

Last Updated: 2023-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-01

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators propose a prospective diagnostic validity study in which the correct location of the central venous catheter will be verified by ultrasound and then verified by radiography in the same patient, without modifying the usual clinical practice criteria.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Catheter Related Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

We propose a prospective diagnostic validity study in which the correct location of the central venous catheter will be verified by ultrasound and then verified by radiography in the same patient, without modifying the usual clinical practice criteria.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CVC location with Rx

After placement of the CVC we will perform the X-ray and subsequent verification of the correct location. Simultaneously, a stopwatch will be started to calculate the time interval until the interpretation of the X-ray by the anesthesiologist.

Group Type ACTIVE_COMPARATOR

Insertion of central venous catheter

Intervention Type DEVICE

Central venous catheter verified by ultrasound and then verified by radiography.

CVC location with echocardiography

Cardiac ultrasound will be performed to visualize the correct position of the CVC tip, and the time until the interpretation of the ultrasound results will also be monitored.

Group Type ACTIVE_COMPARATOR

Insertion of central venous catheter

Intervention Type DEVICE

Central venous catheter verified by ultrasound and then verified by radiography.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insertion of central venous catheter

Central venous catheter verified by ultrasound and then verified by radiography.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age in whom a decision is made to place a supradiaphragmatic central venous catheter.
* Patients who agree to participate in the study

Exclusion Criteria

* Patients with devices that may interfere with the ultrasound images.
* Patients with poor ultrasound window
* Patients with superior vena cava syndrome
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Consorci Sanitari de Terrassa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paula Gil Esteller

Principal Investigator, Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paula Gil Esteller, MD

Role: PRINCIPAL_INVESTIGATOR

Consorci Sanitari de Terrassa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paula Gil Esteller, MD

Role: CONTACT

Phone: +34 628467708

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paula Gil Esteller

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

02-23-270-088

Identifier Type: -

Identifier Source: org_study_id